Microglial imaging with positron emission tomography and atrophy measurements with magnetic resonance imaging in multiple sclerosis: a correlative study

Voxel-Based Morphometry—The Methods

Ashburner, J., & Friston, K. J. (2000) · NeuroImage · doi:10.1006/nimg.2000.0582 · Cited by 8,676 · see citing works

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1032 · Cited by 6,969 · see citing works

Axonal transection in the lesions of multiple sclerosis

Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029 · see citing works

Comparing Functional (PET) Images: The Assessment of Significant Change

Friston, K. J., Frith, C., Liddle, P. F., & Frackowiak, R. S. J. (1991) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1991.122 · Cited by 1,626 · see citing works

Quantitative Measurement of Regional Cerebral Blood Flow and Oxygen Metabolism in Man Using 15O and Positron Emission Tomography

Frackowiak, R. S. J., Lenzi, G.-L., Jones, T., & Heather, J. D. (1980) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-198012000-00001 · Cited by 1,241 · see citing works

Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion

Barnett, M. H., & Prineas, J. W. (2004) · Annals of Neurology · doi:10.1002/ana.20016 · Cited by 1,184 · see citing works

Multimodal Image Coregistration and Partitioning—A Unified Framework

Ashburner, J., & Friston, K. J. (1997) · NeuroImage · doi:10.1006/nimg.1997.0290 · Cited by 932 · see citing works

Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study

Turner, M. R., Cagnin, A., Turkheimer, F. E., Miller, C. C. J., Shaw, C. E., Brooks, D. J., Leigh, P. N., & Banati, R. B. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.012 · Cited by 737 · see citing works

Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS

Rudick, R. A., Fisher, E., Lee, J.-C., Simon, J. H., & Jacobs, L. (1999) · Neurology · doi:10.1212/wnl.53.8.1698 · Cited by 736 · see citing works

Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance

Miller, D. H. (2002) · Brain · doi:10.1093/brain/awf177 · Cited by 628 · see citing works

Myelin-Associated Glycoprotein Is a Myelin Signal that Modulates the Caliber of Myelinated Axons

Yin, X., Crawford, T. O., Griffin, J. W., Tu, P., Lee, V. M. ‐., Li, C. C., Roder, J., & Trapp, B. D. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-06-01953.1998 · Cited by 491 · see citing works

Imaging axonal damage of normal-appearing white matter in multiple sclerosis

Fu, L. (1998) · Brain · doi:10.1093/brain/121.1.103 · Cited by 482 · see citing works

Brain atrophy in clinically early relapsing–remitting multiple sclerosis

Chard, D., Griffin, C., Parker, G. J. M., Kapoor, R., Thompson, A. J., & Miller, D. H. (2002) · Brain · doi:10.1093/brain/awf025 · Cited by 459 · see citing works

Quantitative volumetric analysis of brain MR: normative database spanning 5 decades of life.

Blatter, D. D., Bigler, E. D., Gale, S. D., Johnson, S. C., Anderson, C. V., Burnett, B. M., Parker, N., Kurth, S. M., & Horn, S. D. (1995) · PubMed Central · Cited by 454 · see citing works

A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis

Zivadinov, R. (2001) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.70.6.773 · Cited by 386 · see citing works

Myelination in the absence of myelin-associated glycoprotein

Li, C. C., Tropak, M. B., Gerlai, R. T., Clapoff, S., Abramow-Newerly, W., Trapp, B. D., Peterson, A. C., & Roder, J. (1994) · Nature · doi:10.1038/369747a0 · Cited by 380 · see citing works

Normalization of cerebral volumes by use of intracranial volume: implications for longitudinal quantitative MR imaging.

Whitwell, J. L., Crum, W. R., Watt, H., & Fox, N. C. (2001) · PubMed Central · Cited by 357 · see citing works

A longitudinal study of brain atrophy in relapsing multiple sclerosis

Simon, J. H., Jacobs, L., Campion, M., Rudick, R. A., Cookfair, D. L., Herndon, R. M., Richert, J. R., Salazar, A. Μ., Fischer, J. S., Goodkin, D. E., et al. (1999) · Neurology · doi:10.1212/wnl.53.1.139 · Cited by 337 · see citing works

Imaging of axonal damage in multiple sclerosis: Spatial distribution of magnetic resonance imaging lesions

Narayanan, S., Fu, L., Pioro, E. P., Stefano, N. D., Collins, D. L., Francis, G., Antel, J. P., Matthews, P. M., & Arnold, D. L. (1997) · Annals of Neurology · doi:10.1002/ana.410410314 · Cited by 264 · see citing works

[ 11 C]( R )-PK11195 PET imaging of microglial activation in multiple system atrophy

Gerhard, A., Banati, R. B., Goerres, G. B., Cagnin, A., Myers, R., Gunn, R. N., Turkheimer, F., Good, C. D., Mathias, C. J., Quinn, N. P., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000078192.95645.e6 · Cited by 247 · see citing works

1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis

Davie, C. A., Barker, G. J., Thompson, A. J., Tofts, P. S., McDonald, W. I., & Miller, D. H. (1997) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.63.6.736 · Cited by 227 · see citing works

[ ¹¹ C] <i>(R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen’s encephalitis</i>

Banati, R. B., Goerres, G. W., Myers, R., Gunn, R. N., Turkheimer, F. E., Kreutzberg, G. W., Brooks, D. J., Jones, T., & Duncan, J. S. (1999) · Neurology · doi:10.1212/wnl.53.9.2199 · Cited by 224 · see citing works

PET visualization of microglia in multiple sclerosis patients using [ 11 C]PK11195

Debruyne, J., Versijpt, J. J., Laere, K. V., Vos, F. D., Keppens, J., Strijckmans, K., Achten, E., Slegers, G., Dierckx, R. A., Korf, J., et al. (2003) · European Journal of Neurology · doi:10.1046/j.1468-1331.2003.00571.x · Cited by 217 · see citing works

Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis

Filippi, M. (2000) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.68.2.157 · Cited by 193 · see citing works

Detection of ventricular enlargement in patients at the earliest clinical stage of MS

Brex, P., Jenkins, R., Fox, N. C., Crum, W. R., O’Riordan, J. I., Plant, G. T., & Miller, D. H. (2000) · Neurology · doi:10.1212/wnl.54.8.1689 · Cited by 185 · see citing works

Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patients

Fisher, E., Rudick, R. A., Cutter, G., Baier, M. L., Miller, D. M., Weinstock‐Guttman, B., Mass, M. K., Dougherty, D. S., & Simonian, N. A. (2000) · Multiple Sclerosis Journal · doi:10.1177/135245850000600602 · Cited by 185 · see citing works

A JAVA environment for medical image data analysis: Initial application for brain PET quantitation

Mikolajczyk, K. P., Szabatin, M., Rudnicki, P., Grodzki, M., & Burger, C. (1998) · Medical Informatics · doi:10.3109/14639239809001400 · Cited by 179 · see citing works

Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis

Liu, C., Edwards, S., Gong, Q., Roberts, N., & Blumhardt, L. D. (1999) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.66.3.323 · Cited by 171 · see citing works

In vivo visualization of activated glia by[11C] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion

Cagnin, A. (2001) · Brain · doi:10.1093/brain/124.10.2014 · Cited by 169 · see citing works

Synthesis of N‐(11C) methyl, N‐(methyl‐1 propyl), (chloro‐2 phenyl)‐1 isoquinoleine carboxamide‐3 (PK 11195): A new ligand for peripheral benzodiazepine receptors

Camsonne, R., Crouzel, C., Comar, D., Mazière, M., Prenant, C., Sastre, J., Moulin, M., & Syrota, A. (1984) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.2580211012 · Cited by 166 · see citing works

Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis

Brenner, T., Brocke, S., Szafer, F., Sobel, R. A., Parkinson, J. F., Perez, D., & Steinman, L. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.6.2940 · Cited by 159 · see citing works

Short-term brain volume change in relapsing-remitting multiple sclerosis: Effect of glatiramer acetate and implications

Rovaris, M. (2001) · Brain · doi:10.1093/brain/124.9.1803 · Cited by 153 · see citing works

MRI techniques to monitor MS evolution: The present and the future

Filippi, M., & Grossman, R. (2002) · Neurology · doi:10.1212/wnl.58.8.1147 · Cited by 152 · see citing works

Molecular mechanisms of microglial activation. A. Implications for regeneration and neurodegenerative diseases.

Gebicke‐Haerter, P. J., van Calker, D., Nörenberg, W., & Illés, P. (1996) · PubMed · Cited by 149 · see citing works

Indictment of the microglia as the villain in multiple sclerosis

Sriram, S., & Rodriguez, M. (1997) · Neurology · doi:10.1212/wnl.48.2.464 · Cited by 148 · see citing works

Bicaudate Ratio as a Magnetic Resonance Imaging Marker of Brain Atrophy in Multiple Sclerosis

Bermel, R. A., Bakshi, R., Tjoa, C. W., Puli, S. R., & Jacobs, L. R. (2002) · Archives of Neurology · doi:10.1001/archneur.59.2.275 · Cited by 148 · see citing works

In vivo imaging of microglial activation with [11C](R)‐PK11195 PET in corticobasal degeneration

Gerhard, A., Watts, J., Trender‐Gerhard, I., Turkheimer, F., Banati, R. B., Bhatia, K. P., & Brooks, D. J. (2004) · Movement Disorders · doi:10.1002/mds.20162 · Cited by 145 · see citing works

Both adenosine A1- and A2-receptors are required to stimulate microglial proliferation.

Gebicke‐Haerter, P. J., Christoffel, F., Timmer, J., Northoff, H., Berger, T., & van Calker, D. (1996) · PubMed · Cited by 145 · see citing works

A Longitudinal Study of Callosal Atrophy and Interhemispheric Dysfunction in Relapsing-Remitting Multiple Sclerosis

Pelletier, J., Suchet, L., Witjas, T., Habib, M., Guttmann, C. R. G., Salamon, G., Lyon‐Caen, O., & Chérif, A. A. (2001) · Archives of Neurology · doi:10.1001/archneur.58.1.105 · Cited by 141 · see citing works

Peripheral benzodiazepine receptor imaging in CNS demyelination: functional implications of anatomical and cellular localization

Chen, M., Baidoo, K. E., Verina, T., & Guilarte, T. R. (2004) · Brain · doi:10.1093/brain/awh161 · Cited by 136 · see citing works

Optimizing the association between disability and biological markers in MS

Kalkers, N. F., Bergers, E., Castelijns, J. A., van Walderveen, M. A. A., Bot, J., Adèr, H. J., Polman, C. H., & Barkhof, F. (2001) · Neurology · doi:10.1212/wnl.57.7.1253 · Cited by 132 · see citing works

Brain atrophy in relapsing-remitting multiple sclerosis: relationship with ‘black holes’, disease duration and clinical disability

Paolillo, A., Pozzilli, C., Gasperini, C., Giugni, E., Mainero, C., Giuliani, S., Tomassini, V., Millefiorini, E., & Bastianello, S. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00259-8 · Cited by 124 · see citing works

Labelling of peripheral-type benzodiazepine binding sites in human brain with [3H]PK 11195: Anatomical and subcellular distribution

Doble, A., Malgouris, C., Daniel, M., Daniel, N., Imbault, F., Basbaum, A. I., Uzan, A., Gueremy, C., & Fur, G. L. (1987) · Brain Research Bulletin · doi:10.1016/0361-9230(87)90033-5 · Cited by 118 · see citing works

BOTH ADENOSINE A1- AND A2-RECEPTORS ARE REQUIRED TO STIMULATE MICROGLIAL PROLIFERATION**This is one of eight original papers on the subject “microglia”. Dr Peter Gebicke-Haerter (Dept. Psychiatry, University of Freiburg, Germany) acted as organiser and executive editor in the refereeing of these articles.

Gebicke‐Haerter, P. J., Christoffel, F., Timmer, J., Northoff, H., Berger, T., & van Calker, D. (1996) · Neurochemistry International · doi:10.1016/0197-0186(95)00137-9 · Cited by 115 · see citing works

Brain Atrophy in Relapsing-Remitting Multiple Sclerosis: Fractional Volumetric Analysis of Gray Matter and White Matter

Ge, Y., Grossman, R. I., Udupa, J. K., Babb, J. S., Nyúl, L. G., & Kolson, D. L. (2001) · Radiology · doi:10.1148/radiol.2203001776 · Cited by 112 · see citing works

Molecular mechanisms of axonal damage in inflammatory central nervous system diseases

Neumann, H. (2003) · Current Opinion in Neurology · doi:10.1097/01.wco.0000073926.19076.29 · Cited by 108 · see citing works

Regional Brain Atrophy Is Associated With Physical Disability in Multiple Sclerosis: Semiquantitative Magnetic Resonance Imaging and Relationship to Clinical Findings

Bakshi, R., Benedict, R. H. B., Bermel, R. A., & Jacobs, L. R. (2001) · Journal of Neuroimaging · doi:10.1111/j.1552-6569.2001.tb00022.x · Cited by 89 · see citing works

MRI in the diagnosis and management of multiple sclerosis

Arnold, D. L., & Matthews, P. M. (2002) · Neurology · doi:10.1212/wnl.58.8_suppl_4.s23 · Cited by 86 · see citing works

The Correlation Between Ventricular Diameter Measured by Transcranial Sonography and Clinical Disability and Cognitive Dysfunction in Patients With Multiple Sclerosis

Berg, D., Mäurer, M., Warmuth‐Metz, M., Rieckmann, P., & Becker, G. (2000) · Archives of Neurology · doi:10.1001/archneur.57.9.1289 · Cited by 85 · see citing works

Multiple Sclerosis Therapeutics

Rudick, R. A. (1999) · CRC Press eBooks · doi:10.1201/9781439812242 · Cited by 58 · see citing works

Increased peripheral benzodiazepine binding sites and pentraxin 3 expression in the spinal cord during EAE: relation to inflammatory cytokines and modulation by dexamethasone and rolipram

Agnello, D., Carvelli, L., Muzio, V., Villa, P., Bottazzi, B., Polentarutti, N., Mennini, T., Mantovani, A., & Ghezzi, P. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00279-4 · Cited by 52 · see citing works

Imaging Cerebral Vasculitis in Refractory Epilepsy Using [11C] (R)-PK11195 Positron Emission Tomography

Goerres, G. W., Revesz, T., Duncan, J. S., & Banati, R. B. (2001) · American Journal of Roentgenology · doi:10.2214/ajr.176.4.1761016 · Cited by 51 · see citing works

A longitudinal study of ventricular volume in early relapsing-remitting multiple sclerosis

Luks, T. L., Goodkin, D. E., Nelson, S. J., Majumdar, S., Bacchetti, P., Portnoy, D. A., & Sloan, R. (2000) · Multiple Sclerosis Journal · doi:10.1177/135245850000600507 · Cited by 48 · see citing works

The effect of gadolinium-enhancing lesions on whole brain atrophy in relapsing-remitting MS

Saindane, A. M., Ge, Y., Udupa, J. K., Babb, J. S., Mannon, L. J., & Grossman, R. I. (2000) · Neurology · doi:10.1212/wnl.55.1.61 · Cited by 47 · see citing works

Semiquantification of the peripheral-type benzodiazepine ligand [11C]PK11195 in normal human brain and application in multiple sclerosis patients.

Debruyne, J., van Laere, K. J., Versijpt, J. J., Vos, F. D., Eng, J. K., Strijckmans, K., Santens, P., Achten, E., Slegers, G., Korf, J., et al. (2002) · PubMed · Cited by 41 · see citing works

Quantitative diffusion weighted magnetic resonance imaging, cerebral atrophy, and disability in multiple sclerosis

Wilson, M. (2001) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.70.3.318 · Cited by 40 · see citing works

Peripheral-type benzodiazepine receptors in human cerebral cortex, kidney, and colon

Awad, M., & Gavish, M. (1991) · Life Sciences · doi:10.1016/0024-3205(91)90562-p · Cited by 33 · see citing works

Multiple sclerosis: a white matter disease with associated gray matter damage

Filippi, M. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(01)00476-2 · Cited by 30 · see citing works

Prenatal diazepam induced persisting downregulation of peripheral (ω3) benzodiazepine receptors on rat splenic macrophages

Schlumpf, M., Parmar, R., & LICHTENSTEIGER, W. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90527-a · Cited by 24 · see citing works

Phosphodiesterase type IV inhibitors in the treatment of multiple sclerosis

Dinter, H., Onuffer, J., Faulds, D., & Perez, H. D. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050094 · Cited by 22 · see citing works

Downregulation of [3H]Ro5-4864 binding sites after exposure to peripheral-type benzodiazepines in vitro.

Johnson, J. R., Wang, J. K., Morgan, J. I., & Spector, S. A. (1986) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24364-6 · Cited by 19 · see citing works

Untitled work

Cann, S. A. H., Netten, J. P. V., & Netten, C. V. (2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200003)47:3

Untitled work

(1997) · doi:10.1002/(sici)1097-4547(19971015)50:2

Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders

Rupprecht, R., Papadopoulos, V., Rammes, G., Baghai, T. C., Fan, J., Akula, N., Groyer, G., Adams, D., & Schumacher, M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3295 · Cited by 930 · see citing works

Translocator protein 18 kDa (TSPO): Molecular sensor of brain injury and repair

Chen, M.-K., & Guilarte, T. R. (2008) · Pharmacology &amp; Therapeutics · doi:10.1016/j.pharmthera.2007.12.004 · Cited by 506 · see citing works

The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: From pathology to imaging

Venneti, S., Lopresti, B. J., & Wiley, C. A. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.10.002 · Cited by 373 · see citing works

Noninvasive Molecular Imaging of Neuroinflammation

Jacobs, A. H., Tavitian, B., & the INMiND consortium (2012) · Journal of Cerebral Blood Flow &amp; Metabolism · doi:10.1038/jcbfm.2012.53 · Cited by 245 · see citing works

Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging

Ciccarelli, O., Barkhof, F., Bodini, B., Stefano, N. D., Golay, X., Nicolay, K., Pelletier, D., Pouwels, P. J. W., Smith, S. A., Wheeler‐Kingshott, C. A. M. G., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70101-2 · Cited by 241 · see citing works

Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases

Dupont, A.-C., Largeau, B., Santiago Ribeiro, M., Guilloteau, D., Tronel, C., & Arlicot, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040785 · Cited by 182 · see citing works

Increased PK11195 PET binding in the cortex of patients with MS correlates with disability

Politis, M., Giannetti, P., Su, P., Turkheimer, F., Keihaninejad, S., Wu, K., Waldman, A., Malik, O., Matthews, P. M., Reynolds, R., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182635645 · Cited by 176 · see citing works

In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand ¹¹ C-PK11195

Rissanen, E., Tuisku, J., Rokka, J., Paavilainen, T., Parkkola, R., Rinne, J. O., & Airas, L. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.131698 · Cited by 171 · see citing works

Imaging Microglial Activation During Neuroinflammation and Alzheimer’s Disease

Venneti, S., Wiley, C. A., & Kofler, J. (2008) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-008-9142-2 · Cited by 168 · see citing works

Mechanisms of Neurodegeneration and Axonal Dysfunction in Progressive Multiple Sclerosis

Correale, J., Marrodan, M., & Ysrraelit, M. C. (2019) · Biomedicines · doi:10.3390/biomedicines7010014 · Cited by 167 · see citing works

Clinical aspects of inflammation in Alzheimer's disease

Rosenberg, P. B. (2005) · International Review of Psychiatry · doi:10.1080/02646830500382037 · Cited by 159 · see citing works

A TSPO ligand is protective in a mouse model of multiple sclerosis

Daugherty, D. J., Selvaraj, V., Chechneva, O. V., Liu, X., Pleasure, D., & Deng, W. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201202124 · Cited by 158 · see citing works

In vivo imaging of neuroinflammation in schizophrenia

Pasternak, O., Kubicki, M. R., & Shenton, M. E. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.05.034 · Cited by 153 · see citing works

Neuroimaging Biomarkers of Neurodegenerative Diseases and Dementia

Risacher, S. L., & Saykin, A. J. (2013) · Seminars in Neurology · doi:10.1055/s-0033-1359312 · Cited by 149 · see citing works

Central nervous system macrophages in progressive multiple sclerosis: relationship to neurodegeneration and therapeutics

Kamma, E., Lasisi, W. O., Libner, C., Ng, H.-A. S., & Plemel, J. R. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02408-y · Cited by 137 · see citing works

A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis

Nutma, E., Stephenson, J. A., Gorter, R. P., de Bruin, J., Boucherie, D. M., Donat, C. K., Breur, M., van der Valk, P., Matthews, P. M., Owen, D. R., et al. (2019) · Brain · doi:10.1093/brain/awz287 · Cited by 138 · see citing works

[11C]-DPA-713 and [18F]-DPA-714 as New PET Tracers for TSPO: A Comparison with [11C]-(R)-PK11195 in a Rat Model of Herpes Encephalitis

Doorduin, J., Klein, H. C., Dierckx, R., James, M. L., Kassiou, M., & de Vries, E. F. J. (2009) · Molecular Imaging and Biology · doi:10.1007/s11307-009-0211-6 · Cited by 131 · see citing works

Current paradigm of the 18-kDa translocator protein (TSPO) as a molecular target for PET imaging in neuroinflammation and neurodegenerative diseases

Ching, A. S. C., Kühnast, B., Damont, A., Roeda, D., Tavitian, B., & Dollé, F. (2011) · Insights into Imaging · doi:10.1007/s13244-011-0128-x · Cited by 130 · see citing works

The Positron Emission Tomography Ligand DAA1106 Binds With High Affinity to Activated Microglia in Human Neurological Disorders

Venneti, S., Wang, G., Nguyen, J., & Wiley, C. A. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318188b204 · Cited by 116 · see citing works

Translocator Protein PET Imaging for Glial Activation in Multiple Sclerosis

Oh, U., Fujita, M., Ikonomidou, V. N., Evangelou, I. E., Matsuura, E., Harberts, E. M., Ohayon, J. M., Pike, V. W., Zhang, Y., Zoghbi, S. S., et al. (2010) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-010-9243-6 · Cited by 118 · see citing works

Translocator Protein 18 kDa Negatively Regulates Inflammation in Microglia

Bae, K.-R., Shim, H.-J., Balu, D., Kim, S. R., & Yu, S. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9540-6 · Cited by 115 · see citing works

Imaging of microglia in patients with neurodegenerative disorders

Politis, M. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00096 · Cited by 111 · see citing works

Maintaining brain health by monitoring inflammatory processes: a mechanism to promote successful aging.

Rosano, C., Marsland, A. L., & Gianaros, P. J. (2012) · Europe PMC (PubMed Central) · Cited by 109 · see citing works

PET Imaging of the Peripheral Benzodiazepine Receptor: Monitoring Disease Progression and Therapy Response in Neurodegenerative Disorders

Doorduin, J., de Vries, E. F. J., Dierckx, R. A. J. O., & Klein, H. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208786549443 · Cited by 107 · see citing works

Increased PK11195-PET binding in normal-appearing white matter in clinically isolated syndrome

Giannetti, P., Politis, M., Su, P., Turkheimer, F., Malik, O., Shiva Keihaninejad, A., Wu, K., Waldman, A. D., Reynolds, R., Nicholas, R. S., et al. (2014) · Brain · doi:10.1093/brain/awu331 · Cited by 106 · see citing works

Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis

Datta, G., Colasanti, A., Rabiner, E. A., Gunn, R. N., Malik, O., Ciccarelli, O., Nicholas, R. S., Vlierberghe, E. V., Hecke, W. V., Searle, G. E., et al. (2017) · Brain · doi:10.1093/brain/awx228 · Cited by 99 · see citing works

In Vivo Assessment of Brain White Matter Inflammation in Multiple Sclerosis with¹⁸F-PBR111 PET

Colasanti, A., Guo, Q., Muhlert, N., Giannetti, P., Onega, M., Newbould, R. D., Ciccarelli, O., Rison, S., Thomas, C., Nicholas, R., et al. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.135129 · Cited by 100 · see citing works

Positron emission tomography imaging in neurological disorders

Politis, M., & Piccini, P. P. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6428-3 · Cited by 99 · see citing works

Evaluation of Reference Tissue Models for the Analysis of [ 11 C]( R )-PK11195 Studies

Kropholler, M. A., Boellaard, R., Schuitemaker, A., Folkersma, H., van Berckel, B. N. M., & Lammertsma, A. A. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600289 · Cited by 94 · see citing works

The Diverse Roles of Microglia in the Neurodegenerative Aspects of Central Nervous System (CNS) Autoimmunity

Thompson, K. K., & Tsirka, S. E. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030504 · Cited by 94 · see citing works

Decreased microglial activation in MS patients treated with glatiramer acetate

Ratchford, J. N., Endres, C. J., Hammoud, D. A., Pomper, M. G., Shiee, N., McGready, J., Pham, D. L., & Calabresi, P. A. (2011) · Journal of Neurology · doi:10.1007/s00415-011-6337-x · Cited by 91 · see citing works

Imaging Brain Microglial Activation Using Positron Emission Tomography and Translocator Protein-Specific Radioligands

Owen, D. R., & Matthews, P. M. (2011) · International review of neurobiology · doi:10.1016/b978-0-12-387718-5.00002-x · Cited by 88 · see citing works

Positron emission tomography with computed tomography imaging of neuroinflammation in experimental autoimmune encephalomyelitis

Radu, C. G., Shu, C. J., Shelly, S. M., Phelps, M. E., & Witte, O. N. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610544104 · Cited by 87 · see citing works

A comparison of the high‐affinity peripheral benzodiazepine receptor ligands DAA1106 and (R)‐PK11195 in rat models of neuroinflammation: implications for PET imaging of microglial activation

Venneti, S., Lopresti, B. J., Wang, G., Slagel, S., Mason, N. S., Mathis, C. A., Fischer, M. L., Larsen, N. J., Mortimer, A. D., Hastings, T. G., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04690.x · Cited by 85 · see citing works

Innate Immunity in the Central Nervous System: A Missing Piece of the Autoimmune Encephalitis Puzzle?

Wesselingh, R., Butzkueven, H., Buzzard, K., Tarlinton, D., O'Brien, T. J., & Monif, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02066 · Cited by 83 · see citing works

<i>In vivo</i> imaging of microglial activation by positron emission tomography with <scp>[¹¹C]PBR28</scp> in the <scp>5XFAD</scp> model of <scp>A</scp>lzheimer's disease

Mirzaei, N., Tang, S. P., Ashworth, S., Coello, C., Plisson, C., Passchier, J., Selvaraj, V., Tyacke, R. J., Nutt, D. J., & Sastre, M. (2016) · Glia · doi:10.1002/glia.22978 · Cited by 82 · see citing works

Natalizumab treatment reduces microglial activation in the white matter of the MS brain

Sucksdorff, M., Tuisku, J., Matilainen, M., Vuorimaa, A., Smith, S., Keitilä, J., Rokka, J., Parkkola, R., Nylund, M., Rinne, J., et al. (2019) · Neurology Neuroimmunology &amp; Neuroinflammation · doi:10.1212/nxi.0000000000000574 · Cited by 71 · see citing works

Evaluation of Microglial Activation in Multiple Sclerosis Patients Using Positron Emission Tomography

Airas, L., Nylund, M., & Rissanen, E. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00181 · Cited by 67 · see citing works

Imaging neuroinflammation in multiple sclerosis using TSPO-PET

Airas, L., Rissanen, E., & Rinne, J. (2015) · Clinical and translational imaging · doi:10.1007/s40336-015-0147-6 · Cited by 61 · see citing works

PET tracers for the peripheral benzodiazepine receptor and uses thereof

Schweitzer, P. J., Fallon, B. A., Mann, J. J., & Kumar, J. S. D. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.08.012 · Cited by 70 · see citing works

Radioisotopic Imaging of Neuroinflammation: FIGURE 1.

Winkeler, A., Boisgard, R., Martín, A., & Tavitian, B. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.065680 · Cited by 70 · see citing works

In vivo imaging and characterization of [18F]DPA-714, a potential new TSPO ligand, in mouse brain and peripheral tissues using small-animal PET

Vicidomini, C., Panico, M., Greco, A., Gargiulo, S., Coda, A. R. D., Zannetti, A., Gramanzini, M., Roviello, G. N., Quarantelli, M., Alfano, B., et al. (2014) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2014.11.009 · Cited by 66 · see citing works

Clinical correlates of grey matter pathology in multiple sclerosis

Horáková, D., Kalinčík, T., Dušánková, J. B., & Doležal, O. (2012) · BMC Neurology · doi:10.1186/1471-2377-12-10 · Cited by 66 · see citing works

TSPO ligand PK11195 alleviates neuroinflammation and beta-amyloid generation induced by systemic LPS administration.

Ma, L., Zhang, H., Liu, N., Wang, P.-Q., Guo, W.-Z., Fu, Q., Jiao, L.-B., Ma, Y.-Q., & Mi, W. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.02.001 · Cited by 60 · see citing works

The high affinity peripheral benzodiazepine receptor ligand DAA1106 binds specifically to microglia in a rat model of traumatic brain injury: Implications for PET imaging

Venneti, S., Wagner, A. K., Wang, G. K., Slagel, S., Chen, X., Lopresti, B. J., Mathis, C. A., & Wiley, C. A. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.06.003 · Cited by 62 · see citing works

A Single Neonatal Exposure to BMAA in a Rat Model Produces Neuropathology Consistent with Neurodegenerative Diseases

Scott, L. L., & Downing, T. G. (2017) · Toxins · doi:10.3390/toxins10010022 · Cited by 57 · see citing works

Use of ultrasmall superparamagnetic particles of iron oxide (USPIO)‐enhanced MRI to demonstrate diffuse inflammation in the normal‐appearing white matter (NAWM) of multiple sclerosis (MS) patients: An exploratory study

Vellinga, M. M., Vrenken, H., Hulst, H. E., Polman, C. H., Uitdehaag, B. M. J., Pouwels, P. J. W., Barkhof, F., & Geurts, J. J. G. (2009) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21678 · Cited by 51 · see citing works

Neuroimaging Techniques to Assess Inflammation in Multiple Sclerosis

Tommasin, S., Giannì, C., Giglio, L. D., & Pantano, P. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.07.055 · Cited by 51 · see citing works

[18F]FEPPA a TSPO Radioligand: Optimized Radiosynthesis and Evaluation as a PET Radiotracer for Brain Inflammation in a Peripheral LPS-Injected Mouse Model

Vignal, N., Cisternino, S., Rizzo-Padoin, N., San, C., Hontonnou, F., Gelé, T., Declèves, X., Sarda‐Mantel, L., & Hosten, B. (2018) · Molecules · doi:10.3390/molecules23061375 · Cited by 51 · see citing works

Development of a PET radioligand for potassium channels to image CNS demyelination

Brugarolas, P., Sánchez‐Rodríguez, J. E., Tsai, H., Basuli, F., Cheng, S., Zhang, X., Caprariello, A. V., Lacroix, J. J., Freifelder, R. H., Murali, D., et al. (2018) · Scientific Reports · doi:10.1038/s41598-017-18747-3 · Cited by 50 · see citing works

Neurosteroid Metabolites of Gonadal Steroid Hormones in Neuroprotection: Implications for Sex Differences in Neurodegenerative Disease

Mendell, A. L., & MacLusky, N. J. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00359 · Cited by 41 · see citing works

Detecting neurodegenerative pathology in multiple sclerosis before irreversible brain tissue loss sets in

Schependom, J. V., Guldolf, K., D'hooghe, M. B., Nagels, G., & D’haeseleer, M. (2019) · Translational Neurodegeneration · doi:10.1186/s40035-019-0178-4 · Cited by 42 · see citing works

Imaging Neuroinflammation – from Bench to Bedside

Pulli, B. (2014) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000226 · Cited by 39 · see citing works

PET imaging of glucose metabolism, neuroinflammation and demyelination in the lysolecithin rat model for multiple sclerosis

Faria, D. D. P., de Vries, E. F. J., Sijbesma, J. W. A., Buchpiguel, C. A., Dierckx, R., & Copray, S. C. V. M. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458514526941 · Cited by 39 · see citing works

The translocator protein ligand XBD173 improves clinical symptoms and neuropathological markers in the SJL/J mouse model of multiple sclerosis

Leva, G., Klein, C., Benyounes, J., Hallé, F., Bihel, F. J. ‐., Collongues, N., Seze, J. D., Mensah‐Nyagan, A. G., & Patte‐Mensah, C. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.09.007 · Cited by 39 · see citing works

The TSPO Ligands 2-Cl-MGV-1, MGV-1, and PK11195 Differentially Suppress the Inflammatory Response of BV-2 Microglial Cell to LPS

Azrad, M., Zeineh, N., Weizman, A., Veenman, L., & Gavish, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030594 · Cited by 37 · see citing works

PET imaging in multiple sclerosis

Faria, D. D. P., Copray, S. C. V. M., Buchpiguel, C. A., Dierckx, R., & de Vries, E. F. J. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9544-2 · Cited by 37 · see citing works

Translocator positron-emission tomography and magnetic resonance spectroscopy imaging of brain glial cell activation in multiple sclerosis

Datta, G., Violante, I., Scott, G., Zimmerman, G., Santos-Ribeiro, A., Rabiner, E., Gunn, R., Malik, O., Ciccarelli, O., Nicholas, R., et al. (2016) · Multiple Sclerosis · doi:10.1177/1352458516681504 · Cited by 35 · see citing works

Therapeutic actions of translocator protein (18 kDa) ligands in experimental models of psychiatric disorders and neurodegenerative diseases.

Arbo, B. D., Benetti, F., García-Segura, L., & Ribeiro, M. (2015) · Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.07.007 · Cited by 35 · see citing works

Imaging of microglial activation in MS using PET: Research use and potential future clinical application

Airas, L., Rissanen, E., & Rinne, J. (2017) · Multiple Sclerosis · doi:10.1177/1352458516674568 · Cited by 32 · see citing works

Dynamic molecular monitoring of retina inflammation byin vivoRaman spectroscopy coupled with multivariate analysis

Marro, M., Taubes, A. L., Abernathy, A. M., Balint, S., Moreno, B., Sánchez-Dalmau, B. F., Martínez‐Lapiscina, E. H., Amat‐Roldan, I., Petrov, D. V., & Villoslada, P. (2013) · Journal of Biophotonics · doi:10.1002/jbio.201300101 · Cited by 34 · see citing works

Quantification of (R)-[11C]PK11195 binding in rheumatoid arthritis

Kropholler, M. A., Boellaard, R., Elzinga, E. H., van der Laken, C. J., Maruyama, K., Kloet, R. W., Voskuyl, A. E., Dijkmans, B. A. C., & Lammertsma, A. A. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-0987-7 · Cited by 34 · see citing works

PET Evaluation of Microglial Activation in Non-neurodegenerative Brain Diseases

Ghadery, C., Best, L. A., Pavese, N., Tai, Y., & Strafella, A. P. (2019) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-019-0951-x · Cited by 34 · see citing works

Peripheral benzodiazepine receptors in the brain of cirrhosis patients with manifest hepatic encephalopathy

Iversen, P., Aagaard, D., Bender, D., Rodell, A. B., Munk, O. L., Cumming, P. D., & Keiding, S. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-0052-8 · Cited by 32 · see citing works

The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials

Mahajan, K., & Ontaneda, D. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0561-8 · Cited by 29 · see citing works

Precision Medicine in Multiple Sclerosis: Future of PET Imaging of Inflammation and Reactive Astrocytes

Poutiainen, P., Jaronen, M., Quintana, F. J., & Brownell, A. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00085 · Cited by 31 · see citing works

Neuroinflammatory Imaging Biomarkers: Relevance to Multiple Sclerosis and its Therapy

Tourdias, T., & Dousset, V. (2012) · Neurotherapeutics · doi:10.1007/s13311-012-0155-4 · Cited by 30 · see citing works

Novel MRI and PET markers of neuroinflammation in multiple sclerosis.

Hagens, M., van Berckel, B. N., & Barkhof, F. (2016) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000326 · Cited by 28 · see citing works

11C-(R)-PK11195 PET Imaging of Microglial Activation and Response to Minocycline in Zymosan-Treated Rats

Converse, A. K., Larsen, E. C., Engle, J. W., Barnhart, T. E., Nickles, R. J., & Duncan, I. D. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.082743 · Cited by 29 · see citing works

PET in Multiple Sclerosis

Niccolini, F., Su, P., & Politis, M. (2015) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000000359 · Cited by 23 · see citing works

The translocator protein (18 kDa) and its role in neuropsychiatric disorders

Barichello, T., Simões, L. R., Collodel, A., Giridharan, V. V., Dal‐Pizzol, F., Macêdo, D. S., & Quevedo, J. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.10.010 · Cited by 29 · see citing works

Up‐regulation of PK11195 binding in areas of axonal degeneration coincides with early microglial activation in mouse brain

Pedersen, M. D., Minuzzi, L., Wirenfeldt, M., Meldgaard, M., Slidsborg, C., Cumming, P. D., & Finsen, B. R. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04975.x · Cited by 26 · see citing works

Reference Tissue Models and Blood–Brain Barrier Disruption: Lessons from (R)-[11C]PK11195 in Traumatic Brain Injury

Folkersma, H., Boellaard, R., Vandertop, W. P., Kloet, R. W., Lubberink, M., Lammertsma, A. A., & van Berckel, B. N. M. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.067512 · Cited by 25 · see citing works

In Vivo Imaging of Glial Activation after Unilateral Labyrinthectomy in the Rat: A [18F]GE180-PET Study

Zwergal, A., Gunther, L. M., Brendel, M., Beck, R., Lindner, S., Xiong, G., Eilles, E., Unterrainer, M., Albert, N. L., Becker‐Bense, S., et al. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00665 · Cited by 22 · see citing works

Exploring the role of microglia in mood disorders associated with experimental multiple sclerosis

Gentile, A., Vito, F. D., Fresegna, D., Musella, A., Buttari, F., Bullitta, S., Mandolesi, G., & Centonze, D. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00243 · Cited by 22 · see citing works

PET Imaging of Disease Progression and Treatment Effects in the Experimental Autoimmune Encephalomyelitis Rat Model

Faria, D. D. P., Vlaming, M. L. H., Copray, S. C. V. M., Tielen, F. J., Anthonijsz, H. J. A., Sijbesma, J. W. A., Buchpiguel, C. A., Dierckx, R., van der Hoorn, J. W. A., & de Vries, E. F. J. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.137216 · Cited by 21 · see citing works

Spinal Fluid Myeloid Microvesicles Predict Disease Course in Multiple Sclerosis

Gelibter, S., Pisa, M., Croese, T., Finardi, A., Mandelli, A., Sangalli, F., Colombo, B., Martinelli, V., Comı, G., Filippi, M., et al. (2021) · Annals of Neurology · doi:10.1002/ana.26154 · Cited by 20 · see citing works

Nuclear Imaging of Inflammation in Neurologic and Psychiatric Disorders

de Vries, E. F. J., Dierckx, R., & Klein, H. C. (2006) · Current Clinical Pharmacology · doi:10.2174/157488406778249334 · Cited by 20 · see citing works

Over-expression of TSPO in the hippocampal CA1 area alleviates cognitive dysfunction caused by lipopolysaccharide in mice

Zhang, H., Ma, L., Yin, Y., Dong, L.-Q., Cheng, G., Ma, Y., Li, Y., & Xu, B. (2016) · Brain Research · doi:10.1016/j.brainres.2016.06.001 · Cited by 19 · see citing works

TSPO-PET Imaging to Assess Cerebral Microglial Activation in Multiple Sclerosis

Weiner, H. L., Bakshi, R., & Singhal, T. (2017) · Seminars in Neurology · doi:10.1055/s-0037-1608715 · Cited by 18 · see citing works

Distribution of PK11195 binding sites in porcine brain studied by autoradiography in vitro and by positron emission tomography

Cumming, P. D., Pedersen, M. D., Minuzzi, L., Mezzomo, K. M., Danielsen, E. H., Iversen, P., Aagaard, D., Keiding, S., Munk, O. L., & Finsen, B. R. (2006) · Synapse · doi:10.1002/syn.20257 · Cited by 19 · see citing works

Guanabenz modulates microglia and macrophages during demyelination

Thompson, K. K., & Tsirka, S. E. (2020) · Scientific Reports · doi:10.1038/s41598-020-76383-w · Cited by 17 · see citing works

Beyond monoamines: I. Novel targets and radiotracers for Positron emission tomography imaging in psychiatric disorders

Lopresti, B. J., Royse, S. K., Mathis, C. A., Tollefson, S., & Narendran, R. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15615 · Cited by 16 · see citing works

Magnetic resonance imaging of glutamate in neuroinflammation

Chen, Y., Dai, Z., Shen, Z., Lin, G., Zhuang, C., Li, H. J., & Wu, R. (2016) · Radiology of Infectious Diseases · doi:10.1016/j.jrid.2016.03.006 · Cited by 16 · see citing works

Linking Cognitive Impairment to Neuroinflammation in Multiple Sclerosis using neuroimaging tools

Barros, C., & Fernandes, A. M. A. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102622 · Cited by 15 · see citing works

Investigating the structural network underlying brain-immune interactions using combined histopathology and neuroimaging: a critical review for its relevance in acute and long COVID-19

Kikinis, Z., Castañeyra-Perdomo, A., González–Mora, J. L., Rushmore, J., Toppa, P. H., Haggerty, K., Papadimitriou, G., Yogesh Rathi, A., Kubicki, M. R., Kikinis, R., et al. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1337888 · Cited by 13 · see citing works

Cognitive dysfunction and emotional–behavioural changes in MS: The potential of positron emission tomography

Herholz, K. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.09.012 · Cited by 13 · see citing works

Microglia and Multiple Sclerosis

Hammond, B. P., Panda, S. P., Kaushik, D. K., & Plemel, J. R. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_25 · Cited by 11 · see citing works

GMP-compliant fully automated radiosynthesis of [18F]FEPPA for PET/MRI imaging of regional brain TSPO expression

Chang, C.-W., Chiu, C.-H., Lin, M.-H., Wu, H., Yu, T.-H., Wang, P.-Y., Kuo, Y.-Y., Huang, Y.-Y., Shiue, C., Huang, W.-S., et al. (2021) · EJNMMI Research · doi:10.1186/s13550-021-00768-9 · Cited by 11 · see citing works

Towards molecular imaging of multiple sclerosis

Owen, D. R., Piccini, P. P., & Matthews, P. M. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458510390070 · Cited by 11 · see citing works

Evolving role of MRI in optimizing the treatment of multiple sclerosis: Canadian Consensus recommendations

Arnold, D. L., Li, D., Hohol, M. J., Chakraborty, S., Chankowsky, J., Alikhani, K., Duquette, P., Bhan, V., Montanera, W. J., Rabinovitch, H., et al. (2015) · Multiple Sclerosis Journal - Experimental Translational and Clinical · doi:10.1177/2055217315589775 · Cited by 10 · see citing works

The ligands of translocator protein inhibit human Th1 responses and the rejection of murine skin allografts

Zhang, Y., Yu, S., Li, X., Yang, B., & Wu, C. Y. (2016) · Clinical Science · doi:10.1042/cs20160547 · Cited by 7 · see citing works

Effect of Preventive and Curative Fingolimod Treatment Regimens on Microglia Activation and Disease Progression in a Rat Model of Multiple Sclerosis

García, D. V., Doorduin, J., Faria, D. D. P., Dierckx, R., & de Vries, E. D. (2017) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-017-9741-x · Cited by 6 · see citing works

Measuring Pathology in Patients with Multiple Sclerosis Using Positron Emission Tomography

Brier, M. R., & Taha, F. (2023) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-023-01285-z · Cited by 7 · see citing works

Advances in the molecular imaging of multiple sclerosis

Matthews, P. M., & Comley, R. A. (2009) · Expert Review of Clinical Immunology · doi:10.1586/eci.09.66 · Cited by 7 · see citing works

Cell–cell communication by Endocannabinoids during Immune Surveillance of the Central Nervous System

Ullrich, O., Schneider‐Stock, R., & Zipp, F. (2006) · Springer eBooks · doi:10.1007/400_015 · Cited by 7 · see citing works

Serum glial fibrillary acid protein associates with TSPO-expressing lesions in multiple sclerosis brain

Sjöros, T., Saraste, M., Matilainen, M., Nylund, M., Koivumäki, M., Kühle, J., Leppert, D., & Airas, L. M. (2025) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864251352998 · Cited by 4 · see citing works

Ro5-4864, a translocator protein ligand, regulates T cell-mediated inflammatory responses in skin

Sendai, Y., Takeda, K., Ohta, K., Nakae, S., Koshika, K., Kitamura, K., Higuchi, M., Ichinohe, T., Azuma, T., Okumura, K., et al. (2024) · International Immunology · doi:10.1093/intimm/dxae065 · Cited by 4 · see citing works

PET Imaging of Translocator Protein Expression in Neurological Disorders

Brooks, D. J. (2020) · Springer eBooks · doi:10.1007/978-3-030-53176-8_30 · Cited by 4 · see citing works

Assessment of 18F-PBR-111 in the Cuprizone Mouse Model of Multiple Sclerosis

Jewells, V., Yuan, H., Merrill, J. R., Frank, J. E., Patel, A., Cohen, S. M., Giglio, B. C., Feinberg, N. N., Matsushima, G., & Li, Z.-B. (2021) · Diagnostics · doi:10.3390/diagnostics11050786 · Cited by 1 · see citing works

TSPO-PET-measurable neuroinflammation associates with brain atrophy in multiple sclerosis.

Yenikekaluva, A., Sjöros, T., Matilainen, M., Snellman, A., Rinne, J., Alfaifi, B., Hinz, R., Saraste, M., & Airas, L. (2026) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2026.107207 · Cited by 1 · see citing works

Microglial Activation in the Deep Grey Matter is Associated with Regional Atrophy and Physical Disability in Multiple Sclerosis (S12.003)

Singhal, T., Cicero, S., Chu, R., Dubey, S., O’Connor, K., Tauhid, S., Kijewski, M. F., Weiner, H. L., & Bakshi, R. (2019) · Neurology · doi:10.1212/wnl.92.15_supplement.s12.003

Microglial Activation Correlates with Disease Progression in Multiple Sclerosis (P4.167)

Airas, L. M., Rissanen, E., Tuisku, J., & Rinne, J. O. (2016) · Neurology · doi:10.1212/wnl.86.16_supplement.p4.167 · Cited by 1 · see citing works

Increased Microglial Activation in the Brain of Secondary Progressive Multiple Sclerosis Patients Detected Using [11C]PK11195 PET (S21.003)

Rissanen, E., Tuisku, J., Virta, J. R., Paavilainen, T., Parkkola, R. K., Rinne, J. O., & Airas, L. M. (2012) · Neurology · doi:10.1212/wnl.78.1_meetingabstracts.s21.003

Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis

Datta, G., Colasanti, A., Rabiner, E. A., Gunn, R. N., Malik, O., Ciccarelli, O., Nicholas, R. S., Vlierberghe, E. V., Hecke, W. V., Searle, G. E., et al. (2017) · Brain · doi:10.1093/brain/awx228 · Cited by 99 · see citing works